Sroka Raymond, Gabriel Emmanuel M, Al-Hadidi Danna, Nurkin Steven J, Urman Richard D, Quinn Timothy D
Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Jacobs School of Medicine and Biomedical Sciences, Department of Anesthesiology, State University of New York at Buffalo, Buffalo, NY.
J Healthc Risk Manag. 2019 Jan;38(3):12-23. doi: 10.1002/jhrm.21326. Epub 2018 Jul 23.
The objective of this retrospective analysis was to describe the development and implementation of an anesthesiologist-led multidisciplinary committee to evaluate high-risk surgical patients in order to improve surgical appropriateness. The study was conducted in an anesthesia preoperative evaluation clinic at an academic comprehensive cancer center. One hundred sixty-seven high-risk surgical patients with cancer-related diagnoses were evaluated and discussed at a High-Risk Committee (HRC) meeting to determine surgical appropriateness and optimize perioperative care. The HRC is an anesthesiologist-led model for multidisciplinary review of high-risk patients developed at Roswell Park Comprehensive Cancer Center. The group of high-risk patients in which surgery was not performed had, on average, a greater percentage of hypertension, smoking history, dyspnea, heart failure, chronic obstructive pulmonary disease, diabetes, renal failure, and sleep apnea than the group in whom surgery was performed. Only one of 107 high-risk patients who had surgery died within the first 30 days after surgery. A smaller percentage of patients died in the group that had surgery versus the group in which surgery was canceled. For all patients discussed by the HRC, the mortality was less than 2% within the first 30 days after the HRC.
这项回顾性分析的目的是描述由麻醉医生主导的多学科委员会的组建和实施情况,该委员会旨在评估高风险手术患者,以提高手术的合理性。该研究在一家学术性综合癌症中心的麻醉术前评估诊所进行。167例患有癌症相关诊断的高风险手术患者在高风险委员会(HRC)会议上接受评估和讨论,以确定手术的合理性并优化围手术期护理。HRC是罗斯威尔公园综合癌症中心开发的一种由麻醉医生主导的高风险患者多学科评估模式。未进行手术的高风险患者组中,高血压、吸烟史、呼吸困难、心力衰竭、慢性阻塞性肺疾病、糖尿病、肾衰竭和睡眠呼吸暂停的比例平均高于进行了手术的患者组。107例接受手术的高风险患者中只有1例在术后30天内死亡。与手术取消组相比,手术组的患者死亡率较低。对于HRC讨论的所有患者,在HRC会议后的前30天内死亡率低于2%。